# Kneu Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kneu-health

- Industry: Software
- Headquarters: London, UK
- Website: www.kneu.com
- Total disclosed funding: $5.6M
- Latest round: Seed (Oct 9, 2025)
- Investors on record: 6

## About

Kneu Health Limited, based in the UK, provides neurology-focused digital health solutions, utilizing advanced technology to enhance patient care for Parkinson’s disease and dementia.Founded in 2022, Kneu Health Limited specializes in digital solutions for neurological health. The company is headquartered in London, UK, and has successfully completed one funding round. In October 2025, Kneu raised USD 5.6 mn in SEED funding, involving investors such as Oxford Science Enterprises and Cedars-Sinai Accelerator. The company was founded by an innovative team seeking to address gaps in neurological healthcare.Kneu Health specializes in neurology-focused digital health solutions, primarily through its MHRA-registered and FDA-cleared technology that transforms smartphones into clinical-grade monitors for patients with Parkinson’s disease and dementia. This innovative platform captures continuous patient data, enabling early diagnosis and proactive care, addressing the challenges posed by underdiagnosed and undertreated neurological conditions. The core offerings aim to improve patient confidence, reduce clinician workload, and alleviate pressures on healthcare systems by providing real-time insights that enhance treatment decisions. Kneu serves a diverse clientele, including healthcare providers and institutions such as NHS Trusts, targeting markets in the United Kingdom and internationally, where the demand for advanced neurological care solutions is rising.Kneu Health generates revenue through a subscription-based model, allowing healthcare providers to access its platform and associated services. The company partners with health systems, particularly within the NHS, to implement its technology, offering value through enhanced patient monitoring and management. Clients typically subscribe to tiered service plans that may provide varying levels of data analysis, integration with electronic health records, and ongoing support. This structured approach aids in the financial sustainability of the platform while aligning with healthcare institutions’ objectives to improve patient outcomes efficiently. The company's offerings, particularly focused on Parkinson’s and dementia care, resonate with a growing market prioritizing advanced health technology solutions.In October 2025, Kneu Health Limited raised USD 5.6 mn in SEED funding to accelerate its US expansion. The company plans to bolster its commercial capacity and advance dementia monitoring capabilities. The recent funding will be dedicated to developing new products and launching them, enhancing its presence in targeted geographical regions, particularly the United States.

## Funding rounds

- Seed, Oct 9, 2025, $5.6M — SXSW, Oxford Sciences Enterprises, Cedars-Sinai Accelerator, Jameel Investment Management Company, GK Goh Ventures, Social Impact Enterprises

## Investors

- SXSW — Seed
- Oxford Sciences Enterprises (https://capitalatlas.ai/funds/oxford-sciences-enterprises) — Seed
- Cedars-Sinai Accelerator (https://capitalatlas.ai/funds/cedars-sinai-accelerator) — Seed
- Jameel Investment Management Company (https://capitalatlas.ai/funds/jameel-investment-management-company) — Seed
- GK Goh Ventures (https://capitalatlas.ai/funds/gk-goh-ventures) — Seed
- Social Impact Enterprises (https://capitalatlas.ai/funds/social-impact-enterprises) — Seed